(6-chloro-1-(4-methoxyphenyl)-3,4-dihydro-1H-pyrido[3,4-b]indol-2(9H)-yl)(2-chlorophenyl)methanone

ID: ALA4462305

PubChem CID: 117937363

Max Phase: Preclinical

Molecular Formula: C25H20Cl2N2O2

Molecular Weight: 451.35

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C2c3[nH]c4ccc(Cl)cc4c3CCN2C(=O)c2ccccc2Cl)cc1

Standard InChI:  InChI=1S/C25H20Cl2N2O2/c1-31-17-9-6-15(7-10-17)24-23-18(20-14-16(26)8-11-22(20)28-23)12-13-29(24)25(30)19-4-2-3-5-21(19)27/h2-11,14,24,28H,12-13H2,1H3

Standard InChI Key:  UCOLPJGQIUAZBW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
    4.9249   -3.9420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6260   -3.5262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6142   -2.7105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9013   -2.3106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9363   -4.7571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2324   -5.1744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2427   -5.9907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9563   -6.3909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6609   -5.9686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6471   -5.1536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2165   -3.5466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2017   -2.7344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4486   -3.8115    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9592   -3.1632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4248   -2.5001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0834   -1.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2765   -1.6966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8123   -2.3644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1563   -3.0944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3390   -3.9255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3497   -4.7426    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9681   -7.2080    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2663   -7.6267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300   -0.9565    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.0413   -3.5077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7506   -3.9084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4524   -3.4913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4421   -2.6733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7242   -2.2742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0253   -2.6936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7596   -4.7255    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 12  4  1  0
 11  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  1  5  1  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
 13 11  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  2 20  1  0
 20 21  2  0
  8 22  1  0
 22 23  1  0
 17 24  1  0
 20 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 26 31  1  0
M  END

Associated Targets(non-human)

Human gammaherpesvirus 4 (1538 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.35Molecular Weight (Monoisotopic): 450.0902AlogP: 6.27#Rotatable Bonds: 3
Polar Surface Area: 45.33Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.89CX LogD: 5.89
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.40Np Likeness Score: -0.97

References

1. Tikhmyanova N, Paparoidamis N, Romero-Masters J, Feng X, Mohammed FS, Reddy PAN, Kenney SC, Lieberman PM, Salvino JM..  (2019)  Development of a novel inducer for EBV lytic therapy.,  29  (16): [PMID:31255485] [10.1016/j.bmcl.2019.06.034]

Source